AVVAA World Health Care Products, Inc. (AVVH)

AVVAA World Health Care Products, Inc. (AVVH) Financial Services Profile

AVVAA World Health Care Products, Inc. operates as a biotechnology firm focused on natural personal care solutions, including its Neuroskin line and patented European skincare products, alongside animal grooming treatments, positioning itself within the growing wellness and skincare market.

What Is the Investment Thesis for AVVH?

AVVAA World Health Care Products, Inc. presents a unique investment thesis driven by its focus on natural and therapeutic skincare solutions. The company's Neuroskin product line, which addresses skin irregularities, is positioned to benefit from the growing global skincare market, projected to reach $189.3 billion by 2025. AVVAA's gross margin of 32.1% indicates a solid product pricing strategy, although the company currently operates at a profit margin of -33.6%, highlighting the need for operational efficiencies. The expansion of its distribution rights for patented European skincare products provides an additional revenue stream, while the introduction of natural animal care products diversifies its portfolio and taps into the lucrative pet care market. However, the company faces risks including market competition and regulatory challenges in the skincare industry. Investors should monitor AVVAA's ability to improve profitability and expand its market share in the rapidly evolving personal care sector.

Based on FMP financials and quantitative analysis

AVVH Key Highlights

• Market Cap: $0.00B indicates a current lack of market valuation due to trading on OTC.
• Profit Margin: -33.6% reflects operational challenges that need addressing.
• Gross Margin: 32.1% suggests effective pricing strategies in product offerings.
• Beta: 0.54 indicates lower volatility compared to the market, suggesting stability.
• No dividend yield, reflecting a focus on reinvestment into growth initiatives.

Who Are AVVH's Competitors?

AVVH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AVVH's Key Strengths?

• Established brand presence in the natural skincare market.
• Innovative product formulations with therapeutic benefits.
• Strong distribution network through food and drug channels.

What Are AVVH's Weaknesses?

• Current negative profit margin indicating operational inefficiencies.
• Limited employee base may hinder scalability and growth.
• Dependence on a narrow product line for revenue.

What Could Drive AVVH Stock Higher?

• Launch of new products in the Neuroskin line aimed at expanding market reach.
• Distribution of patented European skincare products enhancing revenue streams.
• Continued marketing efforts to increase brand awareness and consumer engagement.
• Expansion into e-commerce platforms to capture online sales growth.
• Development of natural animal care products targeting the growing pet care market.

What Are the Key Risks for AVVH?

• Financial-distress signal — its Altman Z-Score of -24.60 sits in the distress zone (elevated bankruptcy risk).
• Negative return on equity (-67.3%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Regulatory challenges in the skincare industry could impact product approvals.
• Competition from established brands may limit market share growth.
• Economic downturns could reduce consumer spending on personal care products.
• Supply chain disruptions affecting product availability and costs.

What Are the Growth Opportunities for AVVH?

• Expansion of Neuroskin Product Line: AVVAA's Neuroskin line targets a growing market for over-the-counter skincare solutions, which is projected to expand at a CAGR of 5.3% through 2027. By enhancing product formulations and marketing strategies, AVVAA can capture a larger share of this lucrative segment.
• Distribution Rights for European Skincare Products: The company holds distribution rights for patented European skincare items, which are gaining popularity in the U.S. market. This segment is expected to grow significantly, providing AVVAA with a unique competitive advantage and potential revenue growth.
• Natural Animal Care Products: The pet care market is projected to reach $269.9 billion by 2025, with a growing demand for natural grooming products. AVVAA's entry into this market with its animal care line positions it well to capitalize on this trend, potentially increasing overall revenue.
• E-commerce Growth: The shift towards online shopping presents an opportunity for AVVAA to expand its reach and sales through digital channels. Investing in e-commerce platforms and digital marketing can enhance brand visibility and drive sales growth.
• Collaborations and Partnerships: Forming strategic partnerships with health and wellness influencers or retailers can enhance brand awareness and credibility. Collaborations can also facilitate entry into new markets, driving growth opportunities for AVVAA.

What Opportunities Does AVVH Have?

• Growing demand for natural skincare products in the U.S. market.
• Expansion into the lucrative pet care market.
• Potential for e-commerce growth to reach broader audiences.

What Threats Does AVVH Face?

• Intense competition from established skincare brands.
• Regulatory challenges in the skincare and personal care industry.
• Market volatility affecting consumer spending on non-essential products.

What Are AVVH's Competitive Advantages?

• Unique product formulations targeting specific skin conditions.
• Established distribution rights for patented European skincare products.
• Focus on natural ingredients appealing to health-conscious consumers.
• Diverse product range including both human and animal care solutions.
• Strong brand identity within the niche of therapeutic skincare.

What Does AVVH Do?

AVVAA World Health Care Products, Inc., founded in 1998, is a biotechnology firm headquartered in Richmond, Virginia. Initially focused on personal care solutions, the company has evolved to specialize in the development, manufacturing, and mass-market distribution of its over-the-counter Neuroskin product line. These products are designed to address various skin irregularities, promoting healthy skin clarity and texture. AVVAA's offerings reach consumers through conventional food and drug channels, showcasing its commitment to accessibility and quality. In addition to its proprietary products, AVVAA holds distribution rights for a range of patented European skincare items, which are scientifically developed to treat persistent dermatological conditions such as eczema, psoriasis, and acne. This diversification enhances AVVAA's market position and product portfolio. Furthermore, the company extends its expertise to the animal care sector, providing grooming treatments for pets including dogs, cats, and horses. Since becoming a subsidiary of Gold Quest Capital, Inc. in June 2021, AVVAA has focused on leveraging its innovative product lines to capture a larger share of the global skincare market, which is experiencing significant growth driven by increasing consumer awareness and demand for natural and therapeutic solutions.

What Products and Services Does AVVH Offer?

• Develop and manufacture natural and therapeutic personal care products.
• Market the Neuroskin product line for treating skin irregularities.
• Distribute patented European skincare products targeting dermatological conditions.
• Provide grooming treatments for pets, including dogs, cats, and horses.
• Reach consumers through conventional food and drug channels.
• Focus on innovation in skincare and animal care solutions.

How Does AVVH Make Money?

• Generate revenue through the sale of over-the-counter skincare products.
• Leverage distribution rights for patented European skincare items.
• Expand product offerings in the natural animal care market.
• Utilize mass marketing strategies to reach a broad consumer base.
• Focus on online sales channels to enhance revenue streams.

What Industry Does AVVH Operate In?

The skincare industry is experiencing robust growth, driven by increasing consumer demand for natural and therapeutic products. The global market is expected to grow significantly, with a focus on wellness and self-care trends. AVVAA World Health Care Products, Inc. operates within this expanding market, leveraging its innovative product lines to compete against established brands and new entrants. The competitive landscape includes both large multinational corporations and niche players focusing on specific skincare solutions, creating a dynamic environment for AVVAA to establish its presence.

Who Are AVVH's Key Customers?

• Consumers seeking natural and therapeutic skincare solutions.
• Individuals with persistent dermatological conditions such as eczema and psoriasis.
• Pet owners looking for grooming products for their animals.
• Retailers and pharmacies distributing personal care products.
• Health and wellness enthusiasts interested in natural products.

AVVAA World Health Care Products, Inc. Financial Trajectory

AVVAA World Health Care Products, Inc. (AVVH) reported $26K in revenue for Q1 2026, a decline of 34.4% compared to the prior quarter. The company recorded a net loss of $23K, with diluted EPS of $0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Financial Services. Across the four most recent quarters, AVVH averaged $0.00 in diluted EPS.

Company Profile

AVVAA World Health Care Products, Inc. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Richmond, US. The company is led by CEO Jason Price. AVVH has traded publicly since 2001.

How AVVAA World Health Care Products, Inc. Is Valued

AVVAA World Health Care Products, Inc. carries a market capitalization of $1.55M, placing it in the micro-cap category. Relative to its peer group, AVVH's quantitative score of 48/100 is below the peer average of 65/100.

ROE -67%Key Financial Metrics

Return on equity for AVVAA World Health Care Products, Inc. stands at -67.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -11.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 8.16 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -2.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 2/9Financial Health

AVVAA World Health Care Products, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -24.60 places it in the distress zone, a signal of elevated financial risk.

AVVH Financials

AVVH Latest News

AVVH Analyst Consensus

AVVH MoonshotScore

AVVAA World Health Care Products, Inc. Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources